ABBOTT CARBAMAZEPINE ASSAY— 510(k) K123518

Substantially Equivalent

Microgenics Corporation

FDA 510(k) clearance K123518 for ABBOTT CARBAMAZEPINE ASSAY, Substantially Equivalent on 2013-06-05. Applicant: Microgenics Corporation.

Clearance details

Applicant
Microgenics Corporation
Product code
Code KLT
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Fremont Blvd., CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.